Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2024 Publisher: Milpharm Limited, Ares, Odyssey Business Park, West End Road, South Ruislip HA4 6QD, United Kingdom
Ramipril 5 mg capsules.
| Pharmaceutical Form |
|---|
|
Capsules, hard. Red/White size ‘4’ hard gelatin capsules imprinted with ‘D’ on red cap and ‘42’ on white body with black edible ink filled with white to almost white powder. |
Each hard capsule contains ramipril 5 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ramipril |
Ramiprilat, the active metabolite of the prodrug ramipril, inhibits the enzyme dipeptidylcarboxypeptidase I (synonyms: angiotensin-converting enzyme; kininase II). In plasma and tissue this enzyme catalyses the conversion of angiotensin I to the active vasoconstrictor substance angiotensin II, as well as the breakdown of the active vasodilator bradykinin. Reduced angiotensin II formation and inhibition of bradykinin breakdown lead to vasodilatation. |
| List of Excipients |
|---|
|
Capsule Fill: Hydrophobic colloidal anhydrous silica Printing Ink: Shellac |
Ramipril capsules are available in Clear PVC/ PE/ PVdC- Aluminium blister pack and white opaque HDPE bottle pack.
Pack size:
Blister pack: 7, 10, 14, 20, 21, 28, 30, 42, 50, 56, 60, 90, 98 & 100 capsules.
Bottle pack: 30, 100, 500 & 1000 capsules.
Not all pack sizes may be marketed.
Milpharm Limited, Ares, Odyssey Business Park, West End Road, South Ruislip HA4 6QD, United Kingdom
PL 16363/0357
23/11/2011
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
